{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:16:03Z","timestamp":1774379763528,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-03339-z","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:39:38Z","timestamp":1774334378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of persistent PSA after robot-assisted radical prostatectomy: a high-volume single-center experience"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2376-580X","authenticated-orcid":false,"given":"Halil","family":"Demir\u00e7akan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2763-0777","authenticated-orcid":false,"given":"H\u00fcseyin","family":"G\u00fcltekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7648-6603","authenticated-orcid":false,"given":"Serkan","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-383X","authenticated-orcid":false,"given":"Kazim","family":"Ceviz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-8096","authenticated-orcid":false,"given":"Murat Bu\u011fra","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-6396","authenticated-orcid":false,"given":"Omer Bu\u011fra","family":"Ozergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-9003","authenticated-orcid":false,"given":"Doruk","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0101-6904","authenticated-orcid":false,"given":"C\u00fcneyt","family":"Ozden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"3","key":"3339_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3339_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"3339_CR3","doi-asserted-by":"crossref","unstructured":"Knipper S, Ott S, Schlemmer HP, Grimm MO, Graefen M, Wiegel T. Options for Curative Treatment of Localized Prostate Cancer. Dtsch Arztebl Int. 2021;118:228\u2013236.","DOI":"10.3238\/arztebl.m2021.0026"},{"issue":"18","key":"3339_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Bill-Axelson","year":"2011","unstructured":"Bill-Axelson A, Holmberg L, Ruutu M et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364(18):1708\u20131717","journal-title":"N Engl J Med"},{"issue":"1","key":"3339_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11701-025-02835-y","volume":"19","author":"CC Lee","year":"2025","unstructured":"Lee CC, Chen M, Chien YS, Chung CH, Li JY (2025) Comparison of outcomes of robot-assisted vs. open or laparoscopic of radical prostatectomy: a population-based cohort study. J Robot Surg 19(1):691","journal-title":"J Robot Surg"},{"issue":"1","key":"3339_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12894-024-01563-z","volume":"24","author":"S Hao","year":"2024","unstructured":"Hao S, Wang H, Lin S, Chen H, Xie L, Zheng X (2024) Analysis of risk factors for persistent PSA after radical prostatectomy: results from a high-volume center in Southeast China. BMC Urol 24(1):185 Published 2024 Aug 29","journal-title":"BMC Urol"},{"issue":"10","key":"3339_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N et al (2023) Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21(10):1067\u20131096","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"3339_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/cancers13050948","volume":"13","author":"S Kimura","year":"2021","unstructured":"Kimura S, Urabe F, Sasaki H, Kimura T, Miki K, Egawa S (2021) Prognostic Significance of Prostate-Specific Antigen Persistence after Radical Prostatectomy: A Systematic Review and Meta-Analysis. Cancers (Basel) 13(5):948 Published 2021 Feb 24","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3339_CR9","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.juro.2013.04.073","volume":"190","author":"G Ploussard","year":"2013","unstructured":"Ploussard G, Staerman F, Pierrevelcin J et al (2013) Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy. J Urol 190(5):1750\u20131756","journal-title":"J Urol"},{"issue":"1","key":"3339_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2019.01.048","volume":"76","author":"F Preisser","year":"2019","unstructured":"Preisser F, Chun FKH, Pompe RS et al (2019) Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 76(1):106\u2013114","journal-title":"Eur Urol"},{"issue":"3","key":"3339_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.eururo.2017.07.026","volume":"73","author":"N Fossati","year":"2018","unstructured":"Fossati N, Karnes RJ, Colicchia M et al (2018) Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. Eur Urol 73(3):436\u2013444","journal-title":"Eur Urol"},{"issue":"2","key":"3339_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.juro.2006.03.086","volume":"176","author":"S Sengupta","year":"2006","unstructured":"Sengupta S, Christensen CM, Zincke H et al (2006) Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol 176(2):559\u2013563","journal-title":"J Urol"},{"issue":"5","key":"3339_CR13","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.juro.2009.07.022","volume":"182","author":"DM Moreira","year":"2009","unstructured":"Moreira DM, Presti JC Jr, Aronson WJ et al (2009) Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. J Urol 182(5):2250\u20132255","journal-title":"J Urol"},{"issue":"10","key":"3339_CR14","doi-asserted-by":"publisher","first-page":"e14495","DOI":"10.1111\/ijcp.14495","volume":"75","author":"U Micoogullari","year":"2021","unstructured":"Micoogullari U, Cakici MC, Kisa E et al (2021) A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy. Int J Clin Pract 75(10):e14495","journal-title":"Int J Clin Pract"},{"issue":"4","key":"3339_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"3339_CR16","unstructured":"European Association of Urology (EAU) EAU Guidelines on Prostate Cancer. Presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5"},{"issue":"4","key":"3339_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000447216","volume":"11","author":"DF Osses","year":"2018","unstructured":"Osses DF, van Asten JJ, Tijsterman JD (2018) Cognitive-Targeted versus Magnetic Resonance Imaging-Guided Prostate Biopsy in Prostate Cancer Detection. Curr Urol 11(4):182\u2013188. https:\/\/doi.org\/10.1159\/000447216","journal-title":"Curr Urol"},{"issue":"2","key":"3339_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244\u2013252. https:\/\/doi.org\/10.1097\/PAS.0000000000000530","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"3339_CR19","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/j.clgc.2016.04.010","volume":"14","author":"R Davis","year":"2016","unstructured":"Davis R, Salmasi A, Koprowski C et al (2016) Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice. Clin Genitourin Cancer 14(6):e617\u2013e622. https:\/\/doi.org\/10.1016\/j.clgc.2016.04.010","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"3339_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","volume":"61","author":"A Briganti","year":"2012","unstructured":"Briganti A, Larcher A, Abdollah F et al (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61(3):480\u2013487","journal-title":"Eur Urol"},{"issue":"6","key":"3339_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.eururo.2015.12.010","volume":"69","author":"L Bianchi","year":"2016","unstructured":"Bianchi L, Nini A, Bianchi M et al (2016) The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients. Eur Urol 69(6):1142\u20131148","journal-title":"Eur Urol"},{"issue":"10","key":"3339_CR22","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.7150\/jca.29714","volume":"10","author":"JK Kim","year":"2019","unstructured":"Kim JK, Jeong CW, Ku JH, Kim HH, Kwak C (2019) Prostate specific antigen (PSA) persistence 6 weeks after radical prostatectomy and pelvic lymph node dissection as predictive factor of radiographic progression in node-positive prostate cancer patients. J Cancer 10(10):2237\u20132242 Published 2019 May 21","journal-title":"J Cancer"},{"issue":"1","key":"3339_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11701-016-0606-8","volume":"11","author":"A Kumar","year":"2017","unstructured":"Kumar A, Samavedi S, Mouraviev V et al (2017) Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy. J Robot Surg 11(1):37\u201345","journal-title":"J Robot Surg"},{"issue":"7","key":"3339_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/bco2.367","volume":"5","author":"T Sasaki","year":"2024","unstructured":"Sasaki T, Kobayashi I, Uchida K et al (2024) Cribriform pattern 4\/intraductal carcinoma of the prostate and persistent prostate-specific antigen after radical prostatectomy. BJUI Compass 5(7):709\u2013717 Published 2024 May 15","journal-title":"BJUI Compass"},{"key":"3339_CR25","doi-asserted-by":"publisher","unstructured":"Quarta L, Pellegrino F, Stabile A et al (2025) Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume? Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2025.10.005 (Published online Dec 23)","DOI":"10.1016\/j.euf.2025.10.005"},{"issue":"2","key":"3339_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5173\/ceju.2023.187","volume":"77","author":"U Carbonara","year":"2024","unstructured":"Carbonara U, Adamou C, Darlington Carbin D et al (2024) Predictors of biochemical recurrence after robot-assisted radical prostatectomy: single-centre analysis. Cent Eur J Urol 77(2):189\u2013195. https:\/\/doi.org\/10.5173\/ceju.2023.187","journal-title":"Cent Eur J Urol"},{"issue":"7","key":"3339_CR27","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.21873\/anticanres.17129","volume":"44","author":"K Mitsunari","year":"2024","unstructured":"Mitsunari K, Fukushima H, Kurata H et al (2024) Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy. Anticancer Res 44(7):3149\u20133154. https:\/\/doi.org\/10.21873\/anticanres.17129","journal-title":"Anticancer Res"},{"issue":"6","key":"3339_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","volume":"75","author":"D Tilki","year":"2019","unstructured":"Tilki D, Preisser F, Graefen M, Huland H, Pompe RS (2019) External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort. Eur Urol 75(6):896\u2013900. https:\/\/doi.org\/10.1016\/j.eururo.2019.03.016","journal-title":"Eur Urol"},{"issue":"5","key":"3339_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MOU.0000000000001292","volume":"35","author":"M Longoni","year":"2025","unstructured":"Longoni M, Falkenbach F, Graefen M et al (2025) Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: current evidence and controversial issues. Curr Opin Urol 35(5):510\u2013516. https:\/\/doi.org\/10.1097\/MOU.0000000000001292","journal-title":"Curr Opin Urol"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03339-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:02:29Z","timestamp":1774368149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03339-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3339"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03339-z","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee of Ankara Bilkent City Hospital (approval number: TABED 1-24-221; May 8, 2024). Ethical approval was obtained retrospectively due to the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The requirement for informed consent was waived by the ethics committee because of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"372"}}